Table 8 Influence of different types of stress on cellular- or tissue-specific gene expression49,50,51,52,53,54,55,56,57,58,59,60,61
Stressor | Condition/ dose | Exposure time | Organisms/ tissues/cells | Microarray | Number of sample sets | Fold change ± | Differentially expressed transcripts | Differentially expressed transcripts in % | Reference |
---|---|---|---|---|---|---|---|---|---|
Altered gravity | Microgravity | 20 s | Jurkat T cells | Affymetrix | 67,528 | 1.3 | 279 | 0.41% | This study |
Altered gravity | Microgravity | 5 min | Jurkat T cells | Affymetrix | 67,528 | 1.3 | 1873 | 2.77% | This study |
Dengue virus infection | NA | 48 h | HUVEC | Affymetrix human genome HG-U133A | 22,283 | 4 | 395 | 1.77% | |
Deoxynivalenol | 5–25 mg/kg | 3–24 h | Thymuses, C57Bl6 mice | 4 × 44K whole-genome mouse oligo microarrays G4122F, Agilent | 39,430 | 1.5 | 0–1707 | 0–4.33% | |
Deoxynivalenol | 0.25–0.5 µM | 3–24 h | Jurkat T cells | 4 × 44K human whole-genome Agilent microarray | 27,958 | 1.5 | 24–578 | 0.09–2.07% | |
Deoxynivalenol | 2–4 µM | 6–24 h | PBMC | 4 × 44K human whole-genome Agilent microarray | 27,958 | 1.5 | 487–938 | 1.74–3.36 % | |
Giardia lamblia incubation | NA | 1.5–18 h | Caco-2 cells | Affymetrix GeneChips Human Genome Focus Array | 8746 | 2 | 24–214 | 0.27–2.45 % | |
Heat shock | 42 °C | 1 h | Human peripheral lymphocytes | NA | 4224 | 2.5 | 76 | 1.80% | |
Exercise | NA | 30 min exercise | PBMC human | Affymetrix HU133A GeneChip | >47,000 | No threshold | 311 | 0.66% | |
Exercise | NA | After 60 min post-exercise | PBMC human | Affymetrix HU133A GeneChip | >47,000 | No threshold | 552 | 1.17% | |
Tobacco smoke | NA | 5 min exposure to smoke | PBMC human | NA | 30,000 | No threshold | 153 | 0.51% | |
Western style diet | NA | 3 months | C57Bl/6J mice | Sentrix MouseRef-8 v1 24K Expression BeadChips (Illumina) | 25,600 | 1.2 | 248 | 0.97% | |
Western style diet | NA | 6 months | C57Bl/6J mice | Sentrix MouseRef-8 v1 24K Expression BeadChips (Illumina) | 25,600 | 1.2 | 121 | 0.47% | |
Glucocorticoid stimulated with dexamethasone | 107 M | 18 h | PBMCs | GEM microarray Incyte, St. Louis, MO | 9182 | 1.4 | 1970 | 21.46% | |
Hypoxia | 1% O2 | 16 h | Primary human monocytes | Affymetrix Human Genome-U133A 2.0 GeneChips | 22,283 | 1.5 | 1213 | 5.44% | |
Ionizing radiation | 5 Gy | 4 h post irradiation | Human lymphoblastoid cell lines | Affymetrix U95A_v2 GeneChip microarray | 12,625 | 1.3 | 526 | 4.17% | |
Ultraviolet radiation | 10 J/m2 | 24 h post UV exposure | Human lymphoblastoid cell lines | Affymetrix U95A_v2 GeneChip microarray | 12,625 | 1.3 | 1113 | 8.82% | |
Neutron radiation | 0.25 Gy | Day 1–7 post-irradiation | Mouse blood | Agilent Mouse Gene Expression 4 × 44K v2 Microarray Kit (G4846A) | 39,430 | 1.5 | 46–691 | 0.12–1.75% | |
Neutron radiation | 1 Gy | Day 1–7 post irradiation | Mouse blood | Agilent Mouse Gene Expression 4 × 44K v2 Microarray Kit (G4846A) | 39,430 | 1.5 | 1956–6226 | 4.96–15.79% | |
X-ray radiation | 1 Gy | Day 1–7 post irradiation | Mouse blood | Agilent Mouse Gene Expression 4 × 44K v2 Microarray Kit (G4846A) | 39,430 | 1.5 | 563–765 | 1.43–1.94% | |
X-ray radiation | 4 Gy | Day 1–7 post irradiation | Mouse blood | Agilent Mouse Gene Expression 4 × 44K v2 Microarray Kit (G4846A) | 39,430 | 1.5 | 1585–3577 | 4.02–9.07% | |
Radiation (60 Co) | 10 Gy / 5 × 2 Gy | 24 h post irradiation | MCF7 breast carcinoma | Custom made # | 7680 | 1.5 | 1229/1049 | 16.00/13.67% | |
Radiation (60 Co) | 10 Gy / 5 × 2 Gy | 24 h post irradiation | DU145 prostate carcinoma | Custom made # | 7680 | 1.5 | 614/881 | 7.99/11.47% | |
Radiation (60 Co) | 10 Gy / 5 × 2 Gy | 24 h post irradiation | SF539 gliosarcoma | Custom made # | 7680 | 1.5 | 611/1162 | 7.96/5.13% |